SB1677

The Higher Education Coordinating Board must designate an institution of higher education meeting the act’s stated 2025 Carnegie “Research 1: Very High Research Spending and Doctorate Production” classification. The institution must use existing resources and collaborate with the Department of State Health Services. The law does not name a particular university, and this review does not establish which institution was selected or independently classify any campus. Final law.

The study must examine diabetes-related amputations and recommend ways to prevent amputations associated with diabetic foot ulcers and peripheral artery disease, increase awareness and improve care. It must consider insurance coverage for foot-ulcer therapies, including topical oxygen therapy; timely and equitable access to evidence-supported tools and services; care-quality incentives; and cooperation among interested parties. Requiring these topics to be studied is not a finding that any treatment works for every patient or an order that insurers cover it. Final law.

Required consultation includes the state health commissioner, an endocrinologist, a diabetes-education nurse, a vascular surgeon, a physician, physician assistant or advanced practice registered nurse with prevention expertise, a podiatrist treating diabetic foot ulcers, a VA-affiliated podiatrist or vascular surgeon, a public-health provider representative, at least three people diagnosed with diabetes or who have experienced a related amputation, and an American Diabetes Association representative. The institution may consult others as needed. Final law.

The institution had to submit its report and legislative or other recommendations to DSHS by September 1, 2026. DSHS must post it online with the underlying information and study methods. The act sets the submission deadline; it does not separately specify a number of days for DSHS to post it. This briefing establishes the legal requirements, not whether the now-past deadline was met or the report is currently posted. Final law.

The Senate substitute shifted the study from DSHS to a designated research institution using existing resources, required collaboration with DSHS, and changed the report recipient from the governor and legislature to DSHS. The study topics, consultation groups, report deadline and expiration date remained. The Senate committee, Senate-passed, House committee and final operative texts match; no floor amendments are indexed. Introduced; Senate substitute; Senate-passed; House committee; Final law; Version index; Amendment index.

Compare the published text versions in the official text index. A change is not attributed to a specific amendment here without a verified record.

Patients and clinicians may benefit if the research leads to useful prevention or access policies. The direct duty is to study and report, so reduced amputations, insurance coverage and individual medical savings are not guaranteed outcomes of this act. The institution and DSHS must devote existing staff time and resources to the work. Final law.

The March 25 introduced, April 4 substitute and May 11 Senate-passed fiscal notes anticipate no significant state fiscal impact. The later notes also anticipate no significant local impact and rely on the institution using existing resources and DSHS absorbing its costs. Their “no cost to the state” explanation is a funding assumption, not proof that the study requires no work or has no opportunity cost. No quantified cost or savings table is supplied, and the act makes no appropriation. Introduced fiscal note; Substitute fiscal note; Senate-passed fiscal note; Final law.